Document is current

Any future updates will be listed below

The EMA as a potential driver of competitiveness of orphan medicines in Europe: a focus on regulatory incentives and funding opportunities

Crossref DOI link: https://doi.org/10.1186/s13023-025-04095-3

Published Online: 2025-10-28

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark